Coronary artery disease is common in nonuremic, asymptomatic type 1 diabetic islet transplant candidates

Diabetes Care

Volumn 28, Issue 4, 2005, Pages 866-872

  Senior, Peter A ^a,c   Welsh, Robert C ^b   McDonald, Charlotte G ^a   Paty, Breay W ^a   Shapiro, A M James ^a   Ryan, Edmond A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE DURATION; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FUNCTION; MALE; PANCREAS ISLET TRANSPLANTATION; PREVALENCE; PROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; STENOSIS; UREMIA;

ADULT; AGED; AWARENESS; BLOOD PRESSURE; C-PEPTIDE; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY STENOSIS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; HYPOGLYCEMIA; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SMOKING;

EID: 15944373580     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.4.866     Document Type: Article

References (32)

1. Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AW, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H: The British Diabetic Association Cohort Study II: cause-specific mortality in patients with insulin-treated diabetes mellitus. Diabet Med 16:466-471, 1999
2. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238, 2000
3. Krolewski AS, Kosinski EJ, Warram JH, Leland OS, Busick EJ, Asmal AC, Rand LI, Christlieb AR, Bradley RF, Kahn CR: Magnitude and determinants of coronary artery disease in juvenile-onset, insulin-dependent diabetes mellitus. Am J Cardiol 59:750-755, 1987
4. Valensi P, Sachs RN, Harfouche B, Lormeau B, Paries J, Cosson E, Paycha F, Leutenegger M, Attali JR: Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. Diabetes Care 24:339-343, 2001
5. Manske CL, Wilson RF, Wang Y, Thomas W: Prevalence of, and risk factors for, angiographically determined coronary artery disease in type I-diabetic patients with nephropathy. Arch Intern Med 152:2450-2455, 1992
6. Larsen J, Brekke M, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K: Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 51:2637-2641, 2002
7. Koistinen MJ, Huikuri HV, Korhonen UR, Linnaluoto MK, Kuusi T, Takkunen JT, Taskinen MR: Asymptomatic coronary artery disease in diabetes: relation to common risk factors, lipoproteins, apoproteins and apo E polymorphism. Acta Diabetol 31:210-214, 1994
8. Brown JH, Hunt LP, Vites NP, Short CD, Gokal R, Mallick NP: Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 9:1136-1142, 1994
9. Manske CL, Wang Y, Rector T, Wilson RF, White CW: Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure. Lancet 340:998-1002, 1992
10. Ryan EA, Shandro T, Green K, Paty BW, Senior PA, Bigam D, Shapiro AM, Vantyghem MC: Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes 53:955-962, 2004
11. Do D, West JA, Morise A, Atwood E, Froelicher V: A consensus approach to diagnosing coronary artery disease based on clinical and exercise test data. Chest 111:1742-1749, 1997
12. Herzog CA, Marwick TH, Pheley AM, White CW, Rao VK, Dick CD: Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates. Am J Kidney Dis 33:1080-1090, 1999
13. Manske CL, Thomas W, Wang Y, Wilson RF: Screening diabetic transplant candidates for coronary artery disease: identification of a low risk subgroup. Kidney Int 44:617-621, 1993
14. Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY, Smithline Kinder L, Ellis D, Becker DJ: Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 26:1374-1379, 2003
15. Pajunen P, Taskinen MR, Nieminen MS, Syvanne M: Angiographic severity and extent of coronary artery disease in patients with type 1 diabetes mellitus. Am J Cardiol 86:1080-1085, 2000
16. Airaksinen KE, Koistinen MJ: Association between silent coronary artery disease, diabetes, and autonomic neuropathy: fact or fallacy? Diabetes Care 15:288-292, 1992
17. Paty BW, Ryan EA, Senior PA, McDonald CG, Shapiro AM: The continuous glucose monitor in the assessment of glycemic lability and hypoglycemic risk in islet transplant recipients (Abstract). Diabetes 52 (Suppl. 1):A98, 2003
18. DECODE Study Group: Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 161:397-405, 2001
19. Hanefeld M, Fischer S, Julius U, Schulze J, Schwanebeck U, Schmechel H, Ziegelasch HJ, Lindner J: Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up. Diabetologia 39:1577-1583, 1996
20. Enbergs A, Burger R, Reinecke H, Borggrefe M, Breithardt G, Kerber S: Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J 21:45-52, 2000
21. Davies MJ: Anatomic features in victims of sudden coronary death: coronary artery pathology. Circulation 85:119-124, 1992
22. Starkman HS, Cable G, Hala V, Hecht H, Donnelly CM: Delineation of prevalence and risk factors for early coronary artery disease by electron beam computed tomography in young adults with type 1 diabetes. Diabetes Care 26:433-436, 2003
23. Penfornis A, Zimmermann C, Boumal D, Sabbah A, Meneveau N, Gaultier-Bourgeois S, Bassand JP, Bernard Y: Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing. Diabet Med 18:900-905, 2001
24. Boudreau RJ, Strony JT, duCret RP, Kuni CC, Wang Y, Wilson RF, Schwartz JS, Castaneda-Zuniga WR: Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration. Radiology 175:103-105, 1990
25. Paillole C, Ruiz J, Juliard JM, Leblanc H, Gourgon R, Passa P: Detection of coronary artery disease in diabetic patients. Diabetologia 38:726-731, 1995
26. Driggers DA, Marchant D: Maximizing the exercise stress test: critical factors that enhances its validity. Postgrad Med 105:53-60, 1999
27. Koistinen MJ, Huikuri HV, Pirttiaho H, Linnaluoto MK, Takkunen JT: Evaluation of exercise electrocardiography and thallium tomographic imaging in detecting asymptomatic coronary artery disease in diabetic patients. Br Heart J 63:7-11, 1990
28. Taskiran M, Fritz-Hansen T, Rasmussen V, Larsson HB, Hilsted J: Decreased myocardial perfusion reserve in diabetic autonomic neuropathy. Diabetes 51:3306-3310, 2002
29. Josephson MA, Brown BG, Hecht HS, Hopkins J, Pierce CD, Petersen RB: Non-invasive detection and localization of coronary stenoses in patients: comparison of resting dipyridamole and exercise thallium-201 myocardial perfusion imaging. Am Heart J 103:1008-1018, 1982
30. Brown KA, Heller GV, Landin RS, Shaw LJ, Beller GA, Pasquale MJ, Haber SB: Early dipyridamole (99m)Tc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation 100:2060-2066, 1999
31. Pirsch JD: Medical evaluation for pancreas transplantation: evolving concepts. Transplant Proc 33:3489-3491, 2001
32. Lin K, Stewart D, Cooper S, Davis CL: Pre-transplant cardiac testing for kidney-pancreas transplant candidates and association with cardiac outcomes. Clin Transplant 15:269-275, 2001